The available data indicate that antisense oligonucleotide-induced knockdown of BRD4 in IBD immune cells leads to a downregulation in the production of IFN-γ, IL-17A, and TNF (Franze et al., 2024a). Here, IL17A is linked to inflammatory bowel disease.